Potent β-cell protection in vitro by an isoquinolinone-derived PARP inhibitor

Hormone and Metabolic Research

Volumn 31, Issue 12, 1999, Pages 641-644

  Burkart, V ^a   Blaeser, K ^a   Kolb, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Nicotinamide; PD128763; Poly(ADP ribose)polymerase; Cell death

Indexed keywords

ISOQUINOLINE DERIVATIVE; ISOQUINOLINONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; IN VITRO STUDY; MEDIATOR RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033369685     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978813     Document Type: Article

References (14)

1. 1 Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992; 356: 356-358
2. 2 DeMurcia G, Schreiber V, Molinete M, Saulier B, Poch O, Masson M, Niedergang C, Menissier DeMurcia J. Structure and function of poly(ADP-ribose)polymerase. Mol Cell Biochem 1994; 138: 15-24
3. 3 Heller B, Wang Z-Q, Wagner EF, Radons J, Bürkle A, Fehsel K, Burkart V, Kolb H. Inactivation of the poly(ADP-ribose)polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 1995; 270: 11176-11180
4. 4 Burkart V, Wang Z-Q, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H. Mice lacking the poly(ADP-ribose)polymerase gene are resistant to pancreatic beta cell destruction and to diabetes development induced by streptozocin. Nature Med 1999; 3: 314-319
5. 5 Kolb H, Burkart V. Nicotinamide in type 1 diabetes : mechanism of action revisited. Diab Care 1999; 22 (Suppl. 2): 16-B-20
6. 6 Pozzilli P, Browne PD, Kolb H. Meta-analysis of nicotinamide treatment in patients with recent onset insulin dependent diabetes. Diab Care 1996; 19: 1357-1363
7. 7 Schernthaner G. Progress in the immunointervention of type-1 diabetes mellitus. Horm Metab Res 1995; 27: 547-554
8. 8 Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H, DENIS Group. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. Diabetes 1998; 47: 980-984
9. 9 Gale EA. Nicotinamide: potential for the prevention of type 1 diabetes? Horm Metab Res 1996; 28: 361-364
10. 10 Arundel-Suto CM, Scavone SV, Turner WR, Suto MJ, Sebolt-Leopold JS. Effect of PD128763, a new potent inhibitor of poly(ADP-ribose)polymerase, on X-ray-induced cellular recovery processes in Chinese hamster V79 cells. Radiat Res 1991; 126: 367-371
11. 11 Kallmann B, Burkart V, Kröncke K-D, Kolb-Bachofen V, Kolb H. Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 1992; 51: 671-678
12. 12 Burkart V, Kolb H. Protection of islet cells from inflammatory cell death in vitro. Clin Exp Immunol 1993; 93: 273-278
13. 13 Banasik M, Komura H, Shimoyama M, Ueda K. Specific inhibitors of poly(ADP-ribose)synthetase and mono(ADP-ribosyl)transferase. J Biol Chem 1992; 267: 1569-1575
14. 14 Heller B, Bürkle A, Radons J, Fengler E, Jalowy A, Müller M, Burkart V, Kolb H. Analysis of oxygen radical toxicity in pancreatic islets at the single cell level. Biol Chem Hoppe-Seyler 1994; 375: 597-602